Degenerative disease of basal ganglia, unspecified
ICD-10 G23.9 is a billable code used to indicate a diagnosis of degenerative disease of basal ganglia, unspecified.
Degenerative diseases of the basal ganglia encompass a variety of neurological disorders characterized by progressive degeneration of the basal ganglia structures, which are critical for the regulation of movement. The most notable condition within this category is Parkinson's disease, which manifests through motor symptoms such as tremors, rigidity, bradykinesia, and postural instability. Other extrapyramidal disorders may also fall under this classification, leading to movement disorders that can significantly impact daily functioning. The basal ganglia are involved in the modulation of voluntary motor control, and their degeneration can lead to a range of symptoms beyond motor dysfunction, including cognitive and emotional disturbances. Dopaminergic medications, such as levodopa and dopamine agonists, are commonly prescribed to manage symptoms, but their effectiveness can vary, and long-term use may lead to complications such as motor fluctuations and dyskinesias. Accurate coding of G23.9 is essential for proper treatment planning and reimbursement, as it reflects the complexity and variability of these conditions.
Detailed neurological examination findings, including motor and non-motor symptoms, response to treatment, and any imaging studies.
Patients presenting with tremors, rigidity, and bradykinesia; follow-up visits for medication management.
Ensure that all symptoms are documented, including cognitive and emotional aspects, to support the diagnosis.
Comprehensive patient history, including family history of movement disorders, and documentation of referrals to specialists.
Initial diagnosis of movement disorders, management of symptoms, and coordination of care with specialists.
Documenting the patient's functional status and any impact on daily living activities is crucial.
Used for follow-up visits for patients with degenerative diseases of the basal ganglia.
Documentation of history, examination, and medical decision-making.
Neurologists should ensure that all relevant neurological findings are documented.
G23.9 should be used when the specific degenerative disease of the basal ganglia is not clearly defined in the documentation. Ensure that all relevant clinical details are provided to justify its use.
